RecruitingPhase 3

Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma

Denmark2,000 participantsStarted 2024-12-20

Plain-language summary

The overall aim of the study is to develop a nutritional preventive fish oil supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that both supplementations in higher doses than recommended could reduce the risk of disease development.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* Pregnant Danish women before week 26 with blood levels of EPA+DHA below 4.7% of total fatty acids * No planned use of fish oil supplementations * No endocrine-, heart-, kidney- or auto-immune disorders * No disorders requiring treatment with blood thinning medication

What they're measuring

Early childhood asthma/persistent wheeze age 0-3 years

Timeframe: 3 years

Trial details

NCT IDNCT06560255

SponsorProfessor Klaus Bønnelykke

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10

Contact for this trial

Klaus Bønnelykke, PhD

+45 38677360 kb@copsac.com

View on ClinicalTrials.gov More Asthma trials